Overview

High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the added benefits of increased high-density lipoprotein (HDL) cholesterol serum levels over and above those achieved by lipid lowering therapy guided by current guidelines, in older individuals with cardiovascular disease.
Phase:
Phase 3
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Aging (NIA)
Treatments:
Atorvastatin
Atorvastatin Calcium
Fluvastatin
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Niacin
Niacinamide
Nicotinic Acids
Pravastatin
Rosuvastatin Calcium
Simvastatin